Clinical Trial Update: Lycopene Following Aneurysmal Subarachnoid Haemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Lycopene for patients after aneurysmal subarachnoid hemorrhage; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysm
• Subarachnoid Hemorrhage

Drugs mentioned

• Lycopene (lycopene)

Snippet

Sponsor: University of Cambridge | Conditions: Subarachnoid Hemorrhage, Aneurysm | Phase 2 | Status: UNKNOWN